From: The clinical potential of blood-proteomics in multiple sclerosis
RRt (n = 16) | HC (n = 12) | RRu (n = 6) | p value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
range | mean | SD | range | mean | SD | range | mean | SD | ||
DISEASE DURATION | 2.0-14.0 | 7.43 | 4.5 | 2.9-13.9 | 7.83 | 3.9 | p = 0.15 | |||
AGE AT STUDY | 23.0-65.0 | 42.6 | 11.1 | 22.2-64.3 | 41.8 | 10.6 | 20.9-66.0 | 42.9 | 12.2 | p 1,2,3 ≥ 0.22 |
EDSS | 0.0-5.0 | 2.0 | 1.7 | |||||||
SEX RATIO (♀/♂) | 56%/44% | 58%/42% | 57%/43 |